Modified Charlson comorbidity index as a survival prediction tool for older patients after liver transplantation
10.4174/astr.2023.104.6.358
- Author:
Jiho CHOI
1
;
Eun-Woo CHOI
;
YoungRok CHOI
;
Su young HONG
;
Sanggyun SUH
;
Kwangpyo HONG
;
Eui Soo HAN
;
Jeong-moo LEE
;
Suk Kyun HONG
;
Nam-Joon YI
;
Kwang-Woong LEE
;
Kyung-Suk SUH
Author Information
1. Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
- Publication Type:ORIGINAL ARTICLE
- From:Annals of Surgical Treatment and Research
2023;104(6):358-363
- CountryRepublic of Korea
- Language:English
-
Abstract:
Purpose:An increasing number of older patients now undergo liver transplantation (LT). Although the overall outcomes in older patients are not different from those of younger patients, there is no tool to predict LT prognosis in older patients.We hypothesized that a modified Charlson comorbidity index (mCCI) and 5-factor modified frailty index (mFI-5) can predict outcomes in older patients after LT.
Methods:This retrospective study included 155 patients (aged >65 years) who underwent LT at Seoul National University Hospital. The recipients were subcategorized into 2 groups based on the mCCI score and mFI-5: the low (0–1) and high (2–5) mCCI groups, and low (≤0.4) and high (>0.4) mFI-5 groups. The independent effect of each variable on post-LT survival was determined using the mCCI subgroup, age at transplantation, sex, Child-Turcotte-Pugh score, model for end-stage liver disease (MELD) score, and mFI-5 subgroup.
Results:The high-mCCI group (41 patients) showed significantly lower 1- and 3-month and 1-, 3-, and 5-year survival than the low-mCCI group. Using the Cox regression model, the mCCI, sex, and MELD score remained significant. The mFI-5 was not a significant factor to predict patients’ survival.
Conclusion:The mCCI and MELD scores could be used to predict post-LT survival in older patients.
